Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

Overview of attention for article published in BMC Medicine, February 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 86,680 followers.

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin http://t.co/XsFwfa4Jim

Effective combined #diabetes therapy http://t.co/zaMhusAUzY @BMCMedicine

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.